Aetna September 2017 Medical Policy Updates

Post Views: 1,096

Aetna September 2017 Medical Policy Updates »

The following Medical Policies have been revised.

August 2017

Revised:

September 27, 2017 – 0084 – Eyelid Surgery

September 27, 2017 – 0184 – Pulmonary Hypertension Treatments and Selected Indications of Prostanoids

September 27, 2017 – 0195 – Erythropoiesis Stimulating Agents

September 27, 2017 – 0682 – Microwave Thermotherapy

September 27, 2017 – 0684 – Cetuximab (Erbitux)

September 27, 2017 – 0685 – Bevacizumab (Avastin) for Non-Ocular Indications

September 27, 2017 – 0686 – Oral and Esophageal Brush Biopsy

September 27, 2017 – 0687 – Pemetrexed (Alimta)

September 27, 2017 – 0691 – Exhaled Breath Tests

September 27, 2017 – 0693 – Somatostatin Analogs

September 27, 2017 – 0697 – Intraoperative Electromyographic Monitoring

September 27, 2017 – 0701 – Vascular Endothelial Growth Factor Inhibitors for Ocular Indications

September 27, 2017 – 0705 – Body Surface Potential Mapping

September 27, 2017 – 0707 – Headaches: Invasive Procedures

September 27, 2017 – 0711 – Insulin-Like Growth Factor-1 (IGF-1) Analogues: Mecasermin (Increlex) and Mecasermin Rinfabate (Iplex)

September 27, 2017 – 0716 – Sialolithiasis (Salivary Stones)

September 27, 2017 – 0782 – Hereditary Angioedema

September 27, 2017 – 0792 – Human Fibrinogen Concentrate (RiaSTAP and Fibryna)

September 27, 2017 – 0815 – Ipilimumab (Yervoy)

September 27, 2017 – 0892 – Nivolumab (Opdivo)

September 22, 2017 – 0646 – Voice Therapy

September 22, 2017 – 0648 – Autism Spectrum Disorders

September 22, 2017 – 0649 – Extracorporeal Shock-Wave Therapy for Musculoskeletal Indications and Soft Tissue Injuries

September 22, 2017 – 0650 – Polymerase Chain Reaction Testing: Selected Indications

September 22, 2017 – 0651 – Endovascular Repair of Aortic Aneurysms

September 22, 2017 – 0652 – Therapeutic Phlebotomy

September 22, 2017 – 0655 – Adalimumab (Humira)

September 22, 2017 – 0657 – Tubal Sterilization

September 22, 2017 – 0658 – Psoriasis and Psoriatic Arthritis: Targeted Immune Modulators

September 22, 2017 – 0659 – Radioimmunotherapy for Non-Hodgkin’s Lymphoma: Ibritumomab Tiuxetan (Zevalin) and Tositumomab (Bexxar)

September 22, 2017 – 0660 – Unicompartmental, Bicompartmental, and Bi-unicompartmental Knee Arthroplasties

September 22, 2017 – 0661 – Joint Resurfacing

September 22, 2017 – 0663 – Cerebral Perfusion Studies

September 22, 2017 – 0665 – Constraint-Induced Therapy

September 22, 2017 – 0670 – Xolair (Omalizumab)

September 22, 2017 – 0672 – Pamidronate (Aredia)

September 22, 2017 – 0676 – Electrical Stimulation for Nausea, Vomiting and Motion Sickness (PrimaBella and ReliefBand) and Other Selected Indications

September 22, 2017 – 0677 – Functional Electrical Stimulation and Neuromuscular Electrical Stimulation

September 22, 2017 – 0678 – Gastric Pacing and Gastric Electrical Stimulation

September 22, 2017 – 0689 – Ocular Photoscreening

September 22, 2017 – 0715 – Pharmacogenetic and Pharmacodynamic Testing

September 22, 2017 – 0764 – Alemtuzumab (Campath)

September 22, 2017 – 0787 – Comparative Genomic Hybridization (CGH)

September 21, 2017 – 0106 – Fetal Echocardiography and Magnetocardiography

September 21, 2017 – 0177 – Helicobacter Pylori Infection Testing

September 21, 2017 – 0194 – Spinal Cord Stimulation

September 21, 2017 – 0497 – Hematopoietic Cell Transplantation for Multiple Myeloma

September 15, 2017 – 0904 – Daratumumab (Darzalex)

September 1, 2017 – 0055 – Hematopoietic Colony-Stimulating Factors (CSFs)

Aetna September 2017 Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While Payers typically update medical policies annually, there are many reasons why a Payer might review or update a policy. When reviews occur out of cycle, they may go unnoticed. Policy Alerts keeps you informed of upcoming and unexpected coverage changes affecting your product. Quickly understanding the changes Payers make can help you adjust reimbursement strategies impacting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on Payer decisions in real-time. Whenever changes occur, email notifications containing a summary of those changes are delivered to your inbox. Clients can access detailed coverage reports and medical policies on the interactive Dashboard portal. Save time and keep focused on the important Payer medical policy reviews and coverage decisions affecting your product!

Policy Alerts takes a client-focused hands-on approach and works hard to provide our customers with helpful insights and actionable analytics over raw data. We understand what our clients need and we are dedicated to making sure we provide timely, accurate and always up-to-date reports that can be used to implement and support a successful reimbursement strategy.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.

Aetna